Literature DB >> 11369811

Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?

G Zalba1, F J Beaumont, G San José, A Fortuño, M A Fortuño, J Díez.   

Abstract

BACKGROUND: Increases in oxidant stress, i.e. excessive production of superoxide anion (O2(.-)), have been reported in different models of hypertension. This study was designed to test the hypothesis that increased O2(.-) production, more than diminished nitric oxide (NO) generation, plays a critical role in endothelial dysfunction present in spontaneously hypertensive rats (SHR).
METHODS: The study was performed in 30-week-old normotensive Wistar-Kyoto rats (WKY) and SHR. In addition, 16-week-old SHR were treated with oral irbesartan (average dose 20 mg/kg per day) for 14 weeks (SHR-I). Aortic nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase activity was determined by use of chemiluminescence with lucigenin. Aortic constitutive nitric oxide synthase (cNOS) activity was determined by measuring the conversion of L-arginine to L-citrulline. Vascular responses to acetylcholine were determined by isometric tension studies.
RESULTS: Whereas systolic blood pressure (SBP) was significantly increased in SHR compared with WKY, no differences were observed in SBP between SHR-I and WKY. In SHR compared with WKY, we found significantly greater NADH/NADPH-driven O2(.-) production, similar cNOS-mediated NO production and an impaired vasodilation in response to acetylcholine. Treated SHR had similar NADH/NADPH oxidase activity and significantly lower cNOS activity than the WKY group. Vasodilation in response to acetylcholine was improved in SHR-I.
CONCLUSIONS: These findings suggest that a diminished availability of NO secondary to an enhanced NADH/NADPH oxidase-dependent O2(.-) production may play a critical role in endothelial dysfunction of adult SHR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369811     DOI: 10.1093/ndt/16.suppl_1.2

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

Review 2.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

3.  Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies.

Authors:  Alok Shiomurti Tripathi; Ajay Kumar Timiri; Papiya Mitra Mazumder; Anil Chandewar
Journal:  J Mol Model       Date:  2015-10-01       Impact factor: 1.810

4.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

5.  Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system.

Authors:  Lingyun Wu; M Hossein Noyan Ashraf; Marina Facci; Rui Wang; Phyllis G Paterson; Alison Ferrie; Bernhard H J Juurlink
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

6.  Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.

Authors:  Cecil Stanley Thompson
Journal:  World J Diabetes       Date:  2013-08-15

7.  Low nitric oxide: a key factor underlying copper-deficiency teratogenicity.

Authors:  Soo Jin Yang; Carl L Keen; Louise Lanoue; Robert B Rucker; Janet Y Uriu-Adams
Journal:  Free Radic Biol Med       Date:  2007-09-18       Impact factor: 7.376

8.  NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo.

Authors:  Xiaosun Zhou; H Glenn Bohlen; Steven J Miller; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

Review 9.  Targeted interception of signaling reactive oxygen species in the vascular endothelium.

Authors:  Jingyan Han; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2012-02

10.  HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.

Authors:  Jung-Won Suh; Dong-Ju Choi; Hyuk-Jae Chang; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Kwang-Il Kim; Cheol-Ho Kim; Hyo-Soo Kim; Buyng-Hee Oh; Young-Bae Park
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.